The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary efficacy and safety of fruquintinib as maintenance therapy after first-line treatment in metastatic colorectal cancer (mCRC): A multicenter, randomized, open-label clinical trial (the FRONT study).
 
Xiaojing Xu
No Relationships to Disclose
 
Yiyi Yu
No Relationships to Disclose
 
Qing Liu
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Yuehong Cui
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Qian Li
No Relationships to Disclose
 
Yi Feng
No Relationships to Disclose
 
Li Liang
No Relationships to Disclose
 
Shan Yu
No Relationships to Disclose
 
Minzhi Lv
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose